Huntington National Bank Buys 181 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Huntington National Bank raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 39.9% in the third quarter, Holdings Channel.com reports. The firm owned 635 shares of the company’s stock after acquiring an additional 181 shares during the period. Huntington National Bank’s holdings in Prestige Consumer Healthcare were worth $46,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Ariel Investments LLC raised its position in shares of Prestige Consumer Healthcare by 10.7% during the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock valued at $195,204,000 after buying an additional 274,212 shares during the last quarter. Victory Capital Management Inc. increased its stake in Prestige Consumer Healthcare by 9.0% during the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after acquiring an additional 171,357 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock valued at $113,570,000 after acquiring an additional 255,045 shares in the last quarter. Congress Asset Management Co. lifted its position in shares of Prestige Consumer Healthcare by 7.8% in the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company’s stock worth $62,375,000 after acquiring an additional 62,411 shares during the period. Finally, Boston Trust Walden Corp acquired a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter worth approximately $41,785,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, insider William P’pool sold 8,987 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total value of $735,585.95. Following the transaction, the insider now owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. The trade was a 30.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Adel Mekhail sold 9,063 shares of the firm’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $82.00, for a total value of $743,166.00. Following the completion of the sale, the executive vice president now owns 18,365 shares of the company’s stock, valued at approximately $1,505,930. This trade represents a 33.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 27,935 shares of company stock valued at $2,289,025. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on PBH shares. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of “Moderate Buy” and an average price target of $83.67.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $81.49 on Tuesday. The stock’s fifty day simple moving average is $73.29 and its 200 day simple moving average is $70.23. Prestige Consumer Healthcare Inc. has a one year low of $56.61 and a one year high of $83.83. The firm has a market cap of $4.03 billion, a price-to-earnings ratio of 20.04, a P/E/G ratio of 2.32 and a beta of 0.47. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09. The company had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.07 EPS. On average, analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.